Ghrelin and its promoter variant associated with cardiac hypertrophy

Journal of Human Hypertension

Volumn 26, Issue 7, 2012, Pages 452-457

  Ukkola, O ^a   Paakko T ^a   Kesaniemi Y A ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

genetics; ghrelin; left ventricular hypertrophy; obesity

Indexed keywords

GHRELIN;

ADULT; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DNA FLANKING REGION; ECHOCARDIOGRAPHY; FEMALE; GENETIC VARIABILITY; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HUMAN; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE; UPREGULATION;

BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; GHRELIN; HUMAN GROWTH HORMONE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84863724308     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2011.51     Document Type: Review

References (26)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660.
2. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev 2005; 85: 495-522.
3. Iglesias MJ, Piñ eiro R, Blanco M, Gallego R, Diéguez C, Gualillo O et al. Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. Cardiovasc Res 2004; 62: 481-488.
4. Nagaya N, Kojima M, Uematsu M, Yamagishi M, Hosoda H, Oya H et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 2001; 280: R1483-R1487.
5. Li L, Zhang L, Pang Y, Pan C, Qi Y, Chen L et al. Cardioprotective effects of ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproterenol in rats. Acta Pharmacol Sin 2006; 27: 527-535.
6. Matsumura K, Tsuchihashi T, Fujii K, Abe I, Iida M. Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension 2002; 40: 694-699.
7. Nagaya N, Moriya J, Yasumura Y, Uematsu M, Ono F, Shimizu W et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 2004; 110: 3674-3679.
8. Vestergaard ET, Andersen NH, Hansen TK, Rasmussen LM, Moller N, Sorensen KE et al. Cardiovascular effects of intravenous ghrelin infusion in healthy young men. Am J Physiol Heart Circ Physiol 2007; 293: H3020-H3026.
9. Tesauro M, Schinzari F, Caramanti M, Lauro R, Cardillo C. Metabolic and cardiovascular effects of ghrelin. Int J Pept 2010 Epub 16 Mar 2010.
10. Tritos NA, Kissinger KV, Manning WJ, Danias PG. Association between ghrelin and cardiovascular indexes in healthy obese and lean men. Clin Endocrinol (Oxf) 2004; 60: 60-66.
11. Rodr?́guez A, Gómez-Ambrosi J, Catalán V, Becerril S, Sáinz N, Gil MJ et al. Association of plasma acylated ghrelin with blood pressure and left ventricular mass in patients with metabolic syndrome. J Hypertens 2010; 28: 560-567.
12. Baessler A, Kwitek AE, Fischer M, Koehler M, Reinhard W, Erdmann J et al. Association of the Ghrelin receptor gene region with left ventricular hypertrophy in the general population: results of the MONICA/KORA Augsburg Echocardiographic Substudy. Hypertension 2006; 47: 920-927.
13. Rantala AO, Kauma H, Lilja M, Savolainen MJ, Reunanen A, Kesäniemi YA. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med 1999; 245: 163-174.
14. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17: 863-871.
15. Vasunta RL, Kesäniemi YA, Ukkola O. Plasma adiponectin concentration is associated with ambulatory daytime systolic blood pressure but not with the dipping status. J Hum Hypertens 2010; 24: 545-551.
16. Pöykkö SM, Kellokoski E, Horkko S, Kauma H, Kesaniemi YA, Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003; 52: 2546-2553.
17. Vartiainen J, Kesaniemi YA, Ukkola O. Sequencing analysis of ghrelin gene 50 flanking region: relations between the sequence variants, fasting plasma total ghrelin concentrations, and body mass index. Metabolism 2006; 55: 1420-1425.
18. Sahn DJ, DeMaria A, Kisslo J, Weyman A. The committee on M-mode standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
19. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Gampo E, Sachs I et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
20. Arvat E, Di Vito L, Broglio F, Papotti M, Muccioli G, Dieguez C et al. Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 2000; 23: 493-495.
21. Colao A, Marzullo P, Di Somma C, Lombardi G. Growth hormone and the heart. Clin Endocrinol (Oxf) 2001; 54: 137-154.
22. Shimizu Y, Nagaya N, Teranishi Y, Imazu M, Yamamoto H, Shokawa T et al. Ghrelin improves endothelial dysfunction through growth hormoneindependent mechanisms in rats. Biochem Biophys Res Commun 2003; 310: 830-835.
23. Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/ AKT. J Cell Biol 2002; 159: 1029-1037.
24. Pöykkö SM, Kellokoski E, Ukkola O, Kauma H, Paivansalo M, Kesaniemi YA et al. Plasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males. J Intern Med 2006; 260: 43-52.
25. Berthold HK, Giannakidou E, Krone W, Trégouët DA, Gouni-Berthold I. Influence of ghrelin gene polymorphisms on hypertension and atherosclerotic disease. Hypertens Res 2010; 33: 155-160.
26. Garcia EA, King P, Sidhu K, Ohgusu H, Walley A, Lecoeur C et al. The role of ghrelin and ghrelin-receptor gene variants and promoter activity in type 2 diabetes. Eur J Endocrinol 2009; 161: 307-315.